
About ChromoTek - ptglab
ChromoTek pioneered the development and commercialization of Nanobody-based research reagents. We are the global market and product leader for high quality and reliable Nanobody-based reagents, which assist our customers’ research.
ChromoTek Nanobody-based Reagents - ptglab
ChromoTek offers premium Nanobody-based research tools that provide a higher level of performance than conventional IgG antibodies and these reagents are now available on ptglab.com.
ChromoTek Nanobody-based Reagents | Proteintech | 武汉三鹰 …
ChromoTek offers premium Nanobody-based research tools that provide a higher level of performance than conventional IgG antibodies and these reagents are now available on ptglab.com.
ChromoTek Nano-Traps - ptglab
ChromoTek Nano-Traps are the benchmark in immunoprecipitation (IP) and allow fast and reliable one-step pulldowns of even low expressed proteins. They consist of Nanobodies coupled to beads and are ready-to-use.
ChromoTek - LinkedIn
ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’...
2022年6月8日 · ChromoTek has developed a suite of superior reagents specialized for certain imaging applications using the advantages of its tailor-made Nanobodies. Nanobodies, also termed VHHs, are the smallest known antibodies.
ChromoTek - Crunchbase Company Profile & Funding
ChromoTek GmbH develops immunologic research and detection reagent and tools for proteomics and cell biology. The company was founded in 2008 and is based in Planegg-Martinsried, Germany.
Chronotek Pro
Manage with confidence. Please enable JavaScript to continue using this application.
ChromoTek is now part of Proteintech | Proteintech Group
Proteintech, the benchmark in antibodies, today announces the acquisition of ChromoTek, a manufacturer of Camelid, single-domain antibodies, also known as nanobodies. ChromoTek is the market leader in nanobodies — high-performance recombinant reagents used for breakthrough research discoveries.
Proteintech Acquires ChromoTek, Expanding its Next ... - BioSpace
2020年10月20日 · Proteintech, the benchmark in antibodies, today announces the acquisition of ChromoTek, a manufacturer of Camelid, single-domain antibodies, also known as nanobodies. ChromoTek is the market leader in nanobodies — high-performance recombinant reagents used for breakthrough research discoveries.